Clinicians show modest response to elevated lipoprotein levels in low-risk patients
Elevated Lipoprotein(a) is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), with levels >50 mg/dL affecting 20–30% of the global population.